ADC THERAPEUTICS SA
Patent Owner
Stats
- 7 US PATENTS IN FORCE
- 8 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 7 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 419 Total Citation Count
- Jun 22, 2007 Earliest Filing
- 3 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2011/0223,107 ANTIBODIES THAT SPECIFICALLY BLOCK THE BIOLOGICAL ACTIVITY OF A TUMOR ANTIGENNov 03, 09Sep 15, 11[A61K, C07H, C12N, G01N, A61P, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9828426 Antibodies against kidney associated antigen 1 and antigen binding fragments thereofApr 25, 16Nov 28, 17[A61K, G01N, C07K]
9393302 Antibodies against kidney associated antigen 1 and antigen binding fragments thereofDec 02, 14Jul 19, 16[A61K, G01N, C07K]
8937163 Antibodies against kidney associated antigen 1 and antigen binding fragments thereofMar 28, 12Jan 20, 15[A61K, G01N, C07K]
8580257 Antibodies that specifically block the biological activity of kidney associated antigen 1 (KAAG1)Jul 20, 11Nov 12, 13[A61K, A61P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0039,930 POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCERAbandonedApr 20, 15Feb 11, 16[A61K, C12Q, C07K]
2012/0288,498 POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCERAbandonedJun 07, 12Nov 15, 12[A61K, A61P, C07K]
2012/0128,661 POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCERAbandonedJun 02, 11May 24, 12[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.